Biospecifics Technologies (BSTC) Reports Q2 EPS of $0.24
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Financial Fact:
Operating income (loss): 4.73M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Operating income (loss): 4.73M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Biospecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.24, versus $0.08 reported last year. Revenue for the quarter came in at $4.7 million versus the consensus estimate of $2.6 million.
For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- The LGL Group (LGL) Misses Q2 EPS by 8c
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
